I fund, incubate, and start projects working at the confluence of hardware, software, biotech, Medtech, and Psychedelic medicine; how these technologies intersect to scale the safe effective integration of therapeutic psychedelics into society. Along with fellow YC Alum JR Rahn I founded Synthesis Capital, which founded, funded, and structured the public flotation of Mind Medicine in Canada; the first publicly listed psychedelic Co in history. Now listed on NASDAQ.